Compound heterozygous DYSF gene mutations leading to dysferlinopathy had been reported in the literature (Nguyen et al., 2007; Li et al., 2017; Liu et al., 2018). This evidence concerns the gene DYSF and neuromuscular disease caused by qualitative or quantitative defects of dysferlin.